Mechanism of Action of Direct Thrombin Inhibitors as Compared with Heparin 1m 0s Direct thrombin inhibitors (DTIs) are a new class of anticoagulants that bind directly to thrombin and block its ...

In this multinational, double-blind, randomized trial, we compared vorapaxar with placebo in 12,944 patients who had acute coronary syndromes without ST-segment elevation. The primary end point was a ...

Thrombosis, the clogging of blood vessels, is a major cause of heart attacks and embolism. Scientists have now engineered the first inhibitors of thrombin, a protease promoting thrombosis, that is ...

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic ...

Bleeding is a prevalent complication of liver surgery that negatively affects clinical outcomes. Surgical bleeding of the liver can lead to a significant increase in morbidity and mortality rates, ...

A novel hemostatic sealant based on the in situ gel formation of gelatin catalyzed by thrombin and crosslinked by transglutaminase was designed. The aim of this study was to investigate the efficacy ...

If you get a blood clot in your leg or another large blood vessel called a deep vein thrombosis (DVT), your treatment will include medications known as blood thinners. These drugs, also called ...